...
首页> 外文期刊>Medicine. >Risk of Acute Kidney Injury and Long-Term Outcome in Patients With Acetaminophen Intoxication: A Nationwide Population-Based Retrospective Cohort Study
【24h】

Risk of Acute Kidney Injury and Long-Term Outcome in Patients With Acetaminophen Intoxication: A Nationwide Population-Based Retrospective Cohort Study

机译:乙酰氨基酚中毒患者急性肾损伤和长期结果的风险:全国范围的批评队列队列队列研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Acetaminophen (APAP) intoxication is a common cause of hepatic toxicity and life-threatening hepatic failure. However, few studies have investigated the possible association between APAP intoxication and acute kidney injury (AKI). We constructed a retrospective cohort study to clarify the relationship between APAP intoxication and the risk of AKI. We identified patients with APAP intoxication and selected a comparison cohort that was 1:4 frequency matched according to age, sex, and year of APAP intoxication diagnosis from the Taiwan National Health Insurance Research Database from 1998 to 2010. We analyzed the risks of AKI for patients with APAP intoxication by using Cox proportional hazards regression models. In this study, 2914 patients with APAP intoxication and 11,656 controls were included. The overall risks of developing AKI were 2.41-fold in the patients with APAP intoxication compared with the comparison cohort. After we excluded APAP intoxication patients with coexisting AKI and hepatic failure/hepatitis, the overall risks of developing AKI were still 2.22-fold in the patients with APAP intoxication. There were 2 patients who had end-stage renal disease (ESRD) following APAP intoxication-related AKI. Limitations include retrospective review, selection bias, and absence of data on detail medications used, laboratory investigations and dosage of APAP intoxication. Our long-term cohort study results showed that AKI is a possible adverse effect among patients with APAP intoxication, regardless of whether patients have presented with hepatic toxicity. However, additional studies are necessary to clarify whether such patients can progress to ESRD.
机译:乙酰氨基酚(APAP)中毒是肝脏毒性和危及生命的肝衰竭的常见原因。然而,很少有研究已经研究了APAP中毒与急性肾损伤(AKI)之间的可能关联。我们建立了一个回顾性的队列研究,以澄清APAP中毒与AKI风险之间的关系。我们鉴定了APAP中毒的患者,并选择了1998年至2010年台湾国家健康保险研究数据库的年龄,性别和APAP中毒诊断年龄,性别和APAP中毒年龄匹配的比较队列。我们分析了AKI的风险通过使用COX比例危害回归模型进行APAP中毒的患者。在本研究中,包括APAP中毒和11,656名控制的2914名。与比较队列相比,APAP中毒的患者患有2.41倍的患者的整体风险为2.41倍。除了共存AKI和肝功能衰竭/肝炎的APAP中毒患者之后,APAP中毒的患者仍然仍然是2.22倍的患者。在APAP中毒相关的AKI之后,有2例患有末期肾病(ESRD)。限制包括回顾性审查,选择偏见,以及没有关于细节药物的数据,实验室调查和APAP中毒的剂量。我们的长期队列研究结果表明,无论患者是否患有肝脏毒性,AKI都是AKI患者可能的不利影响。但是,额外的研究是澄清这些患者是否能够进展到ESRD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号